The TYSABRI® (natalizumab) pregnancy exposure registry: preliminary assessment of outcomes

被引：0
|
作者：
Cristiano, L. [1 ]
Bozic, C. [1 ]
Kooijmans, M. [1 ]
机构：
[1] Biogen Idec Inc, Cambridge, MA USA
来源：
JOURNAL OF NEUROLOGY | 2010年 / 257卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P447
引用
收藏
页码：S145 / S145
页数：1
相关论文
共 50 条
  • [1] Preliminary Evaluation of Pregnancy Outcomes from the TYSABRI® (Natalizumab) Pregnancy Exposure Registry
    Cristiano, Lynda
    Bozic, Carmen
    Kooijmans-Coutinho, Mariska
    NEUROLOGY, 2010, 74 (09) : A66 - A66
  • [2] Preliminary evaluation of pregnancy outcomes from the TYSABRI® (natalizumab) Pregnancy Exposure Registry
    Cristiano, L. M.
    Bozic, C.
    Bloomgren, G.
    Liu, Y. -J.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 100 - 101
  • [3] Preliminary evaluation of pregnancy outcomes from the Tysabri® (natalizumab) Pregnancy Exposure Registry
    Cristiano, L.
    Bozic, C.
    Bloomgren, G.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S457 - S457
  • [4] Evaluation of Pregnancy Outcomes from the TYSABRI® (Natalizumab) Pregnancy Exposure Registry
    Cristiano, Lynda
    Friend, Susan
    Bozic, Carmen
    Bloomgren, Gary
    NEUROLOGY, 2013, 80
  • [5] Evaluation of pregnancy outcomes from the Tysabri® (natalizumab) pregnancy exposure registry: a global, observational, follow-up study
    Friend, Susan
    Richman, Sandra
    Bloomgren, Gary
    Cristiano, Lynda M.
    Wenten, Made
    BMC NEUROLOGY, 2016, 16
  • [6] Evaluation of pregnancy outcomes from the Tysabri® (natalizumab) pregnancy exposure registry: a global, observational, follow-up study
    Susan Friend
    Sandra Richman
    Gary Bloomgren
    Lynda M. Cristiano
    Madé Wenten
    BMC Neurology, 16
  • [7] Disease activity and neonatal outcomes after exposure to natalizumab throughout pregnancy
    Thiel, Sandra
    Litvin, Nastassja
    Haben, Sabrina
    Gold, Ralf
    Hellwig, Kerstin
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2024, 95 (06): : 561 - 570
  • [8] TRANSPLANT PREGNANCY REGISTRY INTERNATIONAL: PREGNANCY OUTCOMES WITH EXPOSURE TO MTOR INHIBITORS
    Coscia, Lisa
    Armenti, Dawn
    Constantinescu, Serban
    Moritz, Michael
    TRANSPLANT INTERNATIONAL, 2017, 30 : 152 - 152
  • [9] Pregnancy and fetal outcomes following natalizumab exposure in pregnancy. A prospective, controlled observational study
    Ebrahimi, Neda
    Herbstritt, Sandra
    Gold, Ralph
    Amezcua, Lilyana
    Koren, Gideon
    Hellwig, Kerstin
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (02) : 198 - 205
  • [10] Natalizumab and Pregnancy - Results from the German MS and Pregnancy Registry
    Hellwig, Kerstin
    Haghikia, Aiden
    Gold, Ralf
    NEUROLOGY, 2012, 78
12345